All Posts

ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets

ViVerita Therapeutics today announced a strategic research collaboration with Boehringer Ingelheim aimed at accelerating the discovery...

May 7

Exciting news! Nature Reviews Cancer and Christopher Lowden published a very insightful article on the power of CRISPR-StAR to transform...

Apr 16

Nature Methods highlights CRISPR-StAR, the proprietary CRISPR-screening technology of ViVerita. https://www.nature.com/articles/s41592-02...

Feb 11

ViVerita announces to having executed a licensing deal for CRISPR-StAR and CRISPR-Switch, two proprietary technologies developed by...

Jan 8